| 2013.1.8 Treatment-Free | 2013.6.17 Treating (Low Rd) | 2014.2.3 Treating (Low Rd-CAM) | 2014.4.7 Treatment-Free | 2014.6.2 Treating (Low Rd-CAM) | (Normal Range) |
IL-1β (pg/mL) | <0.125 | <0.125 | 0.27 | <0.125 |
| (≤0.928) |
IL-2 (pg/mL) | <15.6 | <15.6 | <15.6 | <15.6 | <15.6 | (<15.6) |
IL-4 (pg/mL) |
|
|
| <0.25 |
| (<0.25) |
IL-5 (pg/mL) | <3.9 |
|
| <3.9 |
| (<3.9) |
IL-6 (pg/mL) | 1.27 | 1.49 | 7.33 ↑↑ | 2.52↑ | 10.4 ↑↑ | (≤2.41) |
IL-8 (pg/mL) |
|
|
| <8.0 |
| (<8.0) |
IL-10 (pg/mL) | <0.5 |
|
| <0.5 |
| (<7.05) |
IL-12 (pg/mL) | <0.78 |
|
| 0.78 | 1.86 | (≤3.15) |
TNF-α (pg/mL) | <0.55 | <0.55 | 2.19 ↑ | 1.07 | 1.48 | (≤1.79) |
TGF-β1 (pg/mL) |
|
|
| 1.35 | 2.27 ↑ | (0.89 - 1.80) |
IFN-γ (pg/mL) | <1.56 | <1.56 |
| 6.94 | 5.59 | (≤20.6) |